Fish, n-3 polyunsaturated fatty acids, and cardiovascular disease

Nutritional Health: Strategies for Disease Prevention: Third Edition

Volumn , Issue , 2012, Pages 221-246

  McEvoy, Claire ^a   Young, Ian S ^a   Woodside, Jayne V ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

A linolenic acid; Cardiovascular disease; Coronary heart disease; Docosahexaenoic acid; Eicosapentaenioc acid; Fish; Fish oil; n 3 Polyunsaturated fatty acids

Indexed keywords

EID: 84894049571     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-61779-894-8_10     Document Type: Chapter

References (151)

1. Ross R. The pathogenesis of atherosclerosis in a perspective for the 1990's. Nature. 1993;362:801-9.
2. Heller RF, Chinn S, Tunstall-Pedoe H, Rose G. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J. 1984;288:1409-11.
3. Mann JI. Diet and risk of coronary heart disease and type 2 diabetes. Lancet. 2002;360:783-9.
4. Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet. 1979;2:433-5.
5. Emken EA, Adlof RO, Gulley RM. Dietary linoleic acid in fluences desaturation and acylation of deuterium-labelled linoleic and linolenic acids in young adult males. Biochim Biophys Acta. 1994;1213:277-88.
6. Pawlosky RJ, Hibbeln JR, Novotny JA, Salem Jr N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res. 2001;42:1257-65.
7. Ministry of Agriculture, Fisheries and Food. Fatty acids. Seventh supplement to the fifth edition of McCance and Widdowson's The Composition of Foods. London: HMSO; 1998.
8. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205-9.
9. Kromhout D, Feskens EJ, Bowles CH. The protective effect of a small amount of fish on coronary heart disease mortality in an elderly population. Int J Epidemiol. 1995;24:340-5.
10. Shekelle RB, Missell L, Paul O, Shryock AM, Stamler J. Fish consumption and mortality from coronary heart disease. N Engl J Med. 1985;313:820-4.
11. Dolecek TA, Granditis G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet. 1991;66:205-16.
12. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336:1046-53.
13. Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS. N-3 polyunsaturated fatty acids, fatal ischemic disease, and nonfatal myocardial infarction in older adults:the Cardiovascular Health Study. Am J Clin Nutr. 2003;77:319-25.
14. Whelton SP, He J, Whelton PK, Muntner P. Meta-analysis of observational studies on fish intake and coronary heart disease. Am J Cardiol. 2004;93:1119-23.
15. Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659-69.
16. Marckmann P, Gronbaek M. Fish consumption and coronary heart disease mortality: a systematic review of prospective cohort studies. Eur J Clin Nutr. 1999;53:585-90.
17. He K, Song Y, Daviglus ML, et al. Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies. Circulation. 2004;109:2705-11.
18. Zhang J, Sasaki S, Amano K, Kestelot H. Fish consumption and mortality from all causes, ischemic heart disease, and stroke: an ecological study. Prev Med. 1999;28:520-9.
19. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary heart disease among men. N Engl J Med. 1995;332:977-82.
20. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23-8.
21. Kromhout D, Bloemberg BP, Feskens EJ, Hertog MG, Menotti A, Blackburn H. Alcohol, fish, fibre and antioxidant vitamin intake do not explain population differences in coronary heart disease mortality. Int J Epidemiol. 1996;25:753-9.
22. Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol. 1997;145:876-87.
23. Kris-Etherton PM, Harris WS, Appel LJ, for the Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747-57.
24. Kromhout D. Fish consumption and sudden cardiac death. JAMA. 1998;279:65-6.
25. Sheard NF. Fish consumption and risk of sudden cardiac death. Nutr Rev. 1998;56:177-9.
26. Oomen CM, Feskens EJ, Rasanen L, et al. Fish consumption and coronary heart disease mortality in Finland, Italy and the Netherlands. Am J Epidemiol. 2000;151:999-1006.
27. Salonen JT, Seppanen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 2000;148:265-73.
28. Ahlqwist M, Bengtsson C, Lapidus L, Gergdahl IA, Schutz A. Serum mercury concentration in relation to survival, symptoms, and diseases: results from the prospective population study of women in Gothenburg, Sweden. Acta Odontol Scand. 1999;57:168-74.
29. Harris WS, Poston WC, Haddock CK. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis. 2007;193:1-10.
30. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989;2:757-61.
31. Burr ML, Sweetnam PM, Fehily AM. Diet and reinfarction. Eur Heart J. 1994;15:1152-3.
32. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarcto miocardico. Lancet. 1999;354:447-55.
33. Nilsen DW, Albrektsen G, Landmark K, Moen S, Aarsland T, Woie L. Effects of a high dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr. 2001;74:50-6.
34. Burr ML, Ashfield-Watt PAL, Dunstan FDJ, et al. Lack of bene fit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr. 2003;57:193-200.
35. Lavie CJ, Milani RV, Mehra MR, Ventura HO. Omega-3 polyunsaturated fatty acids and cardiovascular diseases. J Am Coll Cardiol. 2009;54:585-94.
36. Rauch B, Schiele R, Schneider S, et al. OMEGA, a randomized, placebo-controlled trial to test the effect of highly puri fied omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation. 2010;122:2152-9.
37. Kromhout D, Giltay EJ, Geleijnse J, for the Alpha Omega Trial Group. n-3 Fatty acids and cardiovascular events after myocardial infarction. N Engl J Med. 2010;363:2015-26.
38. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090-8.
39. von Schacky C, Harris WS. Cardiovascular bene fits of omega-3 fatty acids. Cardiovasc Res. 2007;73:310-5.
40. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113-8.
41. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995;274:1363-7.
42. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time course analysis of the results of the GISSI-Prevenzione. Circulation. 2002;105:1897-903.
43. Leaf A, Kang JX, Xiao Y-F, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation. 2003;107:2646-52.
44. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomised controlled trials. Am J Med. 2002;112:298-304.
45. Lee JH, O'Keefe JH, Lavie CJ, Marchioli R, Harris WS. Omega-3 fatty acids for cardioprotection. Mayo Clin Proc. 2008;83:324-32.
46. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin Cardiol. 2009;32:365-72.
47. Wang C, Harris WS, Cheung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not a -linolenic acid, bene fit cardiovascular disease outcomes in primary- and secondaryprevention studies: a systematic review. Am J Clin Nutr. 2006;84:5-17.
48. Mozaffarian D, Bryson CL, Lemaitre RN, et al. Fish intake and risk of incident heart failure. J Am Coll Cardiol. 2005;45:2015-21.
49. Levitan EB, Wolk A, Mittleman MA. Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men. Eur Heart J. 2009;30:1495-500.
50. Yamagishi J, Nettleton JA, Folsom AR. Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2008;156:965-74.
51. Yamagishi K, Iso H, Date C, et al. Fish, w -3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women. J Am Coll Cardiol. 2008;52:988-96.
52. GISSI-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet. 2008;372:1223-30.
53. Moertl D, Hammer A, Steiner S, et al. Dose-dependent effects of omega-3 polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of in flammation in chronic heart failure of nonischemic origin: a double-blind, placebocontrolled, 3-arm study. Am Heart J. 2011;161:915.e-9.
54. Skerrett PJ, Hennekens CH. Consumption of fish and fish oils and decreased risk of stroke. Prev Cardiol. 2003;6:38-41.
55. Orencia AJ, Daviglus ML, Dyer AR, Shekelle RB, Stamler J. Fish consumption and stroke in men: 30-year findings of the Chicago Western Electric Study. Stroke. 1996;27:204-9.
56. Morris MC, Manson JE, Rosner B, Buring JE, Willett WC, Hennekens CH. Fish consumption and cardiovascular disease in the Physicians' Health Study: a prospective study. Am J Epidemiol. 1995;142:166-75.
57. Iso H, Rexrode KM, Stampfer MJ, et al. Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA. 2001;285:304-12.
58. Keli SO, Feskens EJ, Kromhout D. Fish consumption and risk of stroke: the Zutphen Study. Stroke. 1994;25:328-32.
59. Gillum RF, Mussolino ME, Madans JH. The relationship between fish consumption and stroke incidence: the NHANES I Epidemiologic Follow-up Study. Arch Intern Med. 1996;156:537-42.
60. He K, Rimm EB, Merchant A, et al. Fish consumption and risk of stroke in men. JAMA. 2002;288:3130-6.
61. Mozaffarian D, Longstreth Jr WT, Lemaitre RN, et al. Fish consumption and stroke risk in elderly individuals: the cardiovascular health study. Arch Intern Med. 2005;165:200-6.
62. Myint P, Welch AA, Bingham SA, et al. Habitual fish consumption and risk of incident stroke: the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study. Public Health Nutr. 2006;9:882-8.
63. Montonen J, Järvinen R, Reunanen A, Knekt P. Fish consumption and the incidence of cerebrovascular disease. Br J Nutr. 2009;102:750-6.
64. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon Diet Heart Study. Circulation. 1999;99:779-85.
65. Tanaka K, Ishikawa Y, Yokoyama M, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients. Stroke. 2008;39:2052-8.
66. Charnock JS. Lipids and cardiac arrhythmia. Prog Lipid Res. 1994;33:355-85.
67. Nair SSD, Leitch JW, Falconer J, Garg ML. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action. J Nutr. 1997;127:383-93.
68. Anand RG, Alkadri M, Lavie CJ, Milani RV. The role of fish oil in arrhythmia prevention. J Cardiopulm Rehabil Prev. 2008;28:2-8.
69. Lee KW, Lip GYH. The role of omega-3 fatty acids in the secondary prevention of cardiovascular disease. Q J Med. 2003;96:465-80.
70. Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable de fibrillators: a randomized controlled trial. JAMA. 2005;293:2884-91.
71. Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112:2762-8.
72. Brouwer IA, Zock PL, Camm AJ, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter de fibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA. 2006;295:2613-9.
73. Jenkins DJ, Josse AR, Beyene J, et al. Fish-oil supplementation with implantable cardioverter de fibrillators: a meta-analysis. CMAJ. 2008;178:157-64.
74. Harris WS, Connor WE, Alam N, Illingworth DR. Reduction of postprandial triglyceridaemia in humans by dietary n-3 fatty acids. J Lipid Res. 1988;29:1451-60.
75. Grimsgaard S, Bonaa KH, Hansen JB, Nordoy A. Highly puri fied eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids. Am J Clin Nutr. 1997;66:649-59.
76. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008;197:12-24.
77. Howe PR. Dietary fats and hypertension: focus on fish oil. Ann N Y Acad Sci. 1997;827:339-52.
78. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens. 2002;20:1493-9.
79. Cicero AF, Ertek S, Borghi C. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and treatment. Curr Vasc Pharmacol. 2009;7:330-7.
80. Mori TA. Omega-3 fatty acids and hypertension in humans. Clin Exp Pharmacol Physiol. 2006;33:842-6.
81. Agren JJ, Vaisanen S, Hanninen O, Muller AD, Hornstra G. Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostaglandins Leukot Essent Fatty Acids. 1997;57:419-21.
82. Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J. Interactions between dietary fat, fish and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol. 1997;17:279-86.
83. He K. Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease-eat fish or take fish oil supplement? Prog Cardiovasc Dis. 2009;52:95-114.
84. Shahar E, Folsom AR, Wu KK, et al. Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable pro file. The Atherosclerosis Risk in Communities (ARIC) study. Arterioscler Thromb. 1993;13:1205-12.
85. Archer SL, Green D, Chamberlain M, Dyer AR, Liu K. Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol. 1998;18:1119-23.
86. Johansen O, Brekke M, Seljeflot I, Abdelnoor M, Arnesen H. N-3 fatty acids do not prevent restenosis after coronary angioplasty: results from the CART study. Coronary Angioplasty Restenosis Trial. J Am Coll Cardiol. 1999;33:1619-26.
87. Marckmann P, Bladbjerg EM, Jespersen J. Dietary fish oil (4 g daily) and cardiovascular risk markers in healthy men. Arterioscler Thromb Vasc Biol. 1997;17:3384-91.
88. Abe Y, El-Masri B, Kimball KT, et al. Soluble cell adhesion molecules in hypertriglyceridaemia and potential signi ficance on monocyte adhesion. Arterioscler Thromb Vasc Biol. 1998;18:723-31.
89. Seljeflot I, Arnesen H, Brude IR, Nenseter MS, Drevon CA, Hjermann I. Effects of omega-3 fatty acids and/or antioxidants on endothelial cell markers. Eur J Clin Invest. 1998;28:629-35.
90. Thies F, Garry JMC, Yaqoob P, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomized controlled trial. Lancet. 2003;361:477-85.
91. Brown A, Hu F. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr. 2001;73:673-86.
92. Skulas-Ray AC, Kris-Etherton PM, Harris WS, et al. Dose-response effects of omega-3 fatty acids on triglycerides, in flammation, and endothelial function in healthy persons with moderate hypertriglyceridemia. Am J Clin Nutr. 2011;93:243-52.
93. De Caterina R, Libby P. Control of endothelial leukocyte adhesion molecules by fatty acids. Lipids. 1996;31:S57-63.
94. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr. 2000;71:213S-23.
95. Lopez-Garcia E, Schulze MB, Manson JE, et al. Consumption of (n-3) fatty acids is related to plasma biomarkers of in flammation and endothelial activation in women. J Nutr. 2004;134:1806-11.
96. He K, Liu K, Daviglus ML, et al. Associations of dietary long-chain n-3 polyunsaturated fatty acids and fish with biomarkers of in flammation and endothelial activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]). Am J Cardiol. 2009;103:1238-43.
97. Endres S, von Schacky C. n-3 Polyunsaturated fatty acids and human cytokine synthesis. Curr Opin Lipidol. 1996;7:48-52.
98. Trebble TM, Wootton SA, Miles EA, et al. Prostaglandin E 2 production and T cell function after fish-oil supplementation: response to antioxidant cosupplementation. Am J Clin Nutr. 2003;78:376-82.
99. Hjerkinn EM, Seljeflot I, Ellingsen I, et al. In fluence of long-term intervention with dietary counseling, long-chain n-3 fatty acid supplements, or both on circulating markers of endothelial activation in men with long-standing hyperlipidemia. Am J Clin Nutr. 2005;81:583-9.
100. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-in flammatory potential of long chain omega-3 fatty acids. Nutr Rev. 2010;68:280-9.
101. Simopoulos AP. Omega-3 fatty acids in in flammation and autoimmune disease. J Am Coll Nutr. 2002;21:495-505.
102. Brouwer IA, Katan MB, Zock PL. Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr. 2004;134:919-22.
103. Djousse L, Folsom AR, Province MA, Hunt SC, Ellison RC. Dietary linolenic acid and carotid atherosclerosis: the National Heart, Lung and Blood Institute Family Heart Study. Am J Clin Nutr. 2003;77:819-25.
104. Albert CM, Oh K, Whang W, et al. Dietary-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation. 2005;112:3232-8.
105. Campos H, Baylin A, Willett WC. a -Linolenic acid and risk of non-fatal acute myocardial infarction. Circulation. 2008;118:339-45.
106. Natvig H, Borchgrevink CF, Dedichen J, Owren PA, Schiotz EH, Westlund K. A controlled trial of the effect of linolenic acid on the incidence of coronary heart disease. Scand J Clin Lab Med. 1968;105:S1-20.
107. Bemelmans WJ, Broer J, Feskens EJ, et al. Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alphalinolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr. 2002;75:221-7.
108. Lee JH, O'Keefe JH, Lavie CJ, Harris WS. Omega-3 fatty acids: cardiovascular bene fits, sources and sustainability. Nat Rev Cardiol. 2009;6:753-8.
109. Scientific Advisory Committee on Nutrition. Advice on fish consumption: bene fits and risks. London: Stationary Of fice; 2004. www.food.gov.uk/multimedia/pdfs/ fishreport200401.pdf. Accessed 13 Sept 2010.
110. Oken E, Belfort MB. Fish, fish oil, and pregnancy. JAMA. 2010;304:1717-8.
111. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and bene fits. JAMA. 2006;296:1885-99.
112. Horvath A, Koletzko B, Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-analysis of randomized controlled trials. Br J Nutr. 2007;98:253-9.
113. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by preeclampsia or intrauterine growth restriction. Cochrane Database Syst Rev. 2006;3:CD003402.
114. Mendez MA, Plana E, Guxens M, et al. Seafood consumption in pregnancy and infant size at birth: results from a prospective Spanish cohort. J Epidemiol Community Health. 2010;64:216-22.
115. Oken E, Bellinger DC. Fish consumption, methylmercury and child neurodevelopment. Curr Opin Pediatr. 2008;20:178-83.
116. Hibbeln JR, Davis JM, Steer C, et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study. Lancet. 2007;369:578-85.
117. Terry PD, Rohan TE, Wolk A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr. 2003;77:532-43.
118. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther. 1999;83:217-44.
119. Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92:1223-33.
120. MacLean CH, Newberry SJ, Mojica WA, et al. Effects of omega-3 fatty acids on cancer risk:a systematic review. JAMA. 2006;295:403-15.
121. Fearon KC, Barber MD, Moses AG, et al. Double blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol. 2006;24:3401-7.
122. Dewey A, Baughan C, Dean TP, Higgins B, Johnson I. Eicosapentaenoic acid (EPA, an omega-3 fatty acid from fish oils) for the treatment of cancer cachexia. Cochrane Database Syst Rev. 2007;1:CD004597.
123. Friedland RP. Fish consumption and the risk of Alzheimer disease. Is it time to make dietary recommendations? Arch Neurol. 2003;60:923-4.
124. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids. 2000;35:1305-12.
125. Schaefer EJ, Bongard V, Beiser AS, et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: The Framingham Heart Study. Arch Neurol. 2006;63:1545-50.
126. Morris MC, Evans DA, Bienias J, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003;60:940-6.
127. Quinn JF, Raman R, Thomas RG, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304:1903-11.
128. Coon KD, Myers AJ, Craig DW. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007;68:613-8.
129. Barberger-Gateau P, Raffaitin C, Letenneur L, et al. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology. 2007;69:1921-30.
130. Huang TL, Zandi PP, Tucker KL, et al. Bene fits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology. 2005;65:1409-14.
131. Rennie KL, Hughes J, Lang R, Jebb SA. Nutritional management of rheumatoid arthritis: a review of the evidence. J Hum Nutr Diet. 2003;16:97-109.
132. Cleland LG, James MJ, Proudman SM. The role of fish oils in the treatment of rheumatoid arthritis. Drugs. 2003;63:845-53.
133. Calder P. Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on 'Nutrition and autoimmune disease' PUFA, in flammatory process and rheumatoid arthritis. Proc Nutr Soc. 2008;67:409-18.
134. Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation. 2003;107:1852-7.
135. Djousse L, Gaziano JM, Buring JE, Lee I-M. Dietary omega-3 fatty acids and fish consumption and risk of type 2 diabetes. Am J Clin Nutr. 2011;93:143-50.
136. Vessby B, Karlsrom B, Boberg M, Lithell H, Berne C. Polyunsaturated fatty acids may impair blood glucose control in type 2 diabetic patients. Diabet Med. 1992;9:126-33.
137. Hartweg J, Perera R, Montori VM, et al. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus (review). Cochrane Database Syst Rev. 2008;1:CD003205.
138. Friedberg CE, Janssen MJ, Heine RJ, Grobbee DE. Fish oil and glycemic control in diabetes. A meta-analysis. Diabetes Care. 1998;21:494-500.
139. Simopoulos AP. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids. 1999;60:421-9.
140. Harris WS, Ginsberg HN, Arunakul N, et al. Safety and efficacy of Omacor in severe hypertriglyceridaemia. J Cardiovasc Risk. 1997;4:385-91.
141. De Deckere EAM. Health effects of fish and n-3 polyunsaturated fatty acids from plant and marine origin. In: Wilson T, Temple NJ, editors. Nutritional health: strategies for disease prevention. Totowa, NJ: Humana Press; 2001. p. 195-206.
142. Lox CD. The effects of dietary marine oils (omega-3 fatty acids) on coagulation pro files in men. Gen Pharmacol. 1990;21:241-6.
143. Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65:1645S-54.
144. Hau MF, Smelt AH, Bindels AJ, et al. Effects of fish oil on oxidation resistance of VLDL in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol. 1996;16:1197-202.
145. Sorensen NS, Marckmann P, Hoy CE, van Duyvenvoorde W, Princen HM. Effect of fish-oilenriched margarine on plasma lipids, low-density-lipoprotein particle composition, size, and susceptibility to oxidation. Am J Clin Nutr. 1998;68:235-41.
146. Brude IR, Drevon CA, Hjermann I, et al. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants. Arterioscler Thromb Vasc Biol. 1997;17:2576-88.
147. Bonanome A, Biasia F, De Luca M, et al. n-3 Fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglycerolemic hemodialyzed subjects. Am J Clin Nutr. 1996;63:261-6.
148. Higdon JV, Du SH, Lee YS, Wu T, Wander RC. Supplementation of postmenopausal women with fish oil does not increase overall oxidation of LDL ex vivo compared to dietary oils rich in oleate and linoleate. J Lipid Res. 2001;42:407-18.
149. Food Standards Agency. Dietary recommendations for fish and shell fish. http://tna. europarchive.org/20110116113217/cot.food.gov.uk/pdfs/ fishreport2004full.pdf. Accessed 8 July 2011.
150. SeaChoice. Canada's seafood guide. http://www.seachoice.org. Accessed 15 Sept 2011.
151. Lee DH, Jacobs DR. Inconsistent epidemiological findings on fish consumption may be indirect evidence of harmful contaminants in fish. J Epidemiol Community Health. 2010;64:190-2.